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Migraine is a common neurological disorder which affects a large proportion of
the population. The Norfolk Island population is a genetically isolated popula-
tion and is an ideal discovery cohort for genetic variants involved in complex
disease susceptibility given the reduced genetic and environmental heterogene-
ity. Given that the majority of proteins responsible for mitochondrial
function are nuclear encoded, this study aimed to investigate the role of
Nuclear Encoded Mitochondrial Protein (NEMP) genes in relation to migraine
susceptibility.
Methods
A gene-centric association analysis of NEMP genes was undertaken in the most
related individuals (n = 315) within the genetically isolated Norfolk Island pop-
ulation. The discovery phase included genes with three or more SNP associa-
tions (P < 0.005), which were investigated further in a replication phase using
an unrelated migraine case–control cohort (544 patients and 584 controls).
Results
The discovery phase of the study implicated SNPs in 5 NEMP genes to be asso-
ciated with migraine susceptibility (P < 0.005). Replication analysis validated
some of these implicated genes with SNPs in three NEMP genes shown to be
associated with migraine in the replication cohort. These were CSNK1G3
(P = 0.00037), ELOVL6 (P = 0.00035) and SARDH (P = 0.00081), which are
involved in phosphorylation, fatty acid metabolism, and oxidative demethyla-
tion, respectively.
Conclusion
Here we provide evidence that variation in NEMP genes is associated with
migraine susceptibility. This study provides evidence for a link between mito-
chondrial function and migraine susceptibility.
Introduction
The mitochondria is the energy producing organelle pre-
sent in all mammalian cells, occurring in numbers pro-
portional to the energy requirements of each specific
tissue. Muscle fibers and neuronal networks have the
highest energy requirements in the human body and each
cell can contain several thousand mitochondria ensuring
that the demand for ATP is met. Consequently genetic
aberrations which inhibit the Oxidative Phosphorylation
(OXPHOS) pathway have a profound impact on energy
production and most adversely affect the muscle and
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neuronal cells (Sparaco et al. 2006). Deleterious muta-
tions with high rates of penetrance have devastating
effects and cause a range of myopathies and encephalopa-
thies including: Mitochondrial Encephalomyopathy; lactic
acidosis and stroke like episodes (MELAS) (Prasad et al.
2014), and Myoclonic Epilepsy with ragged red fibers
(MERRF) (Wallace et al. 1988). Symptoms of these dis-
eases include severe migraine attacks which has led
researchers to hypothesize that mitochondrial dysfunction
may be linked to the more common subtypes of migraine
(Stuart and Griffiths 2012). Migraine is a costly disorder,
being listed as one of the top twenty most debilitating
diseases by the World Health Organisation (WHO), and
presents significant economic and personal burden (Leo-
nardi et al. 2005). Migraine affects approximately 12% of
the adult general population and is classified by the Inter-
national Headache Society into two main subtypes namely
migraine without aura (MO) and migraine with aura
(MA) (Olesen and Lipton 1994).
The mitochondria itself contains its own genome, made
up of just 37 genes. These genes are transcribed to pro-
duce 22 tRNAs, two rRNAs and 13 polypeptides. The
tRNA and rRNA molecules are involved in forming ribo-
somal units and translating the 13 polypeptides into pro-
teins which form critical components of the OXPHOS
subunits. Complex I is composed of 46 polypeptides of
which seven are mitochondrially encoded, complex III is
made up of just one of 11 mitochondrially encoded
polypeptides and complex IV has three of 13. Similarly
only two of 16 proteins in complex V are encoded by the
mitochondria (Wallace 2005). All the other components
of OXPHOS including the entire subunit II are encoded
by nuclear genes. In addition to structural components of
OXPHOS, all the mitochondrial metabolic enzymes, tran-
scription factors, and other regulatory molecules which
govern mitochondrial function are nuclear encoded
(Pagliarini et al. 2008). Current estimates are that more
than 1000 proteins are encoded by the nuclear DNA and
imported into the mitochondrial matrix (Gioio et al.
2001). The vast majority of active molecules involved in
mitochondrial function are imported into the matrix
from the nucleus in this way with <1% of mitochondrial
function attributed to the mitochondrial genome itself
(Hendrickson et al. 2010). Through this understanding of
mitochondrial function, it is clear that investigation of
nuclear encoded mitochondrial protein (NEMP) genes is
critical for discovering the underlying genetic cause of
mitochondrial disorders.
The purpose of this study was to investigate the role of
NEMPs in relation to migraine susceptibility. We hypoth-
esized that mitochondrial dysfunction, which is influenced
heavily by NEMP genes (Lu and Claypool 2015), could
lower the threshold for a migraine attack and that by
understanding the genetic etiology of this disease new
approaches to migraine treatment/management may be
identified. The link between mitochondrial dysfunction
and migraine was first suggested in the 1980s and since
then a growing body of evidence has strengthened this
hypothesis (Sparaco et al. 2006; Stuart and Griffiths 2012;
Yorns and Hardison 2013). Strong evidence from bio-
chemical, morphological, and therapeutic studies show a
link between mitochondrial dysfunction and migraine
susceptibility (Montagna et al. 1994; Sangiorgi et al. 1994;
Okada et al. 1998; Finnila et al. 2001; D’Andrea et al.
2006; Brenner 2010; Yorns and Hardison 2013). However,
genetic studies have been limited by sample size and
molecular data making this an area that needs to be
addressed. This study aimed to use the genetically isolated
Norfolk Island population as a discovery cohort for iden-
tification of NEMP genes involved with migraine suscep-
tibility and to replicate significant findings in a large
Australian Caucasian migraine patient-control population
to validate the role of identified variants in this common
neurological disorder. Norfolk Island is a genetically iso-
lated population situated off the coast of Australia, best
known from the “Bounty on the Mutiny” historical
account. This isolate is an ideal population for identifica-
tion of complex disease traits as the genetic heterogeneity
typical of these diseases is reduced. Geographical isolation
further reduces environmental heterogeneity and environ-
ment-gene interactions, increasing the chance of identify-
ing true causal variants (Bellis et al. 2005; Macgregor
et al. 2010).
Materials and Methods
Discovery phase – using the genetically
isolated Norfolk Island population
Sample selection
The Norfolk Island population is a genetically isolated
population situated off the east coast of Australia and is
an ideal discovery cohort for genetic variants involved in
complex disease susceptibility given the reduced genetic
and environmental heterogeneity. The most related Core
Pedigree individuals were selected to maximize the poten-
tial for discovering disease causing variation and n = 315
individuals were included in this study. The selected indi-
viduals consisted of 80 migraine sufferers and 235 healthy
controls with migraine affected individuals occurring in
large family subbranches of the pedigree. Several migraine
affected individuals in the same family occurred across as
many as four generations of the Core Pedigree. Ethical
approval has been obtained from the QUT Ethics for
Human Research Committee for this study (Approval
Number 1400000749).
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Molecular methods
DNA samples were genotyped using on the Illumina Bead
Array 500GX Reader. using Illumina Infinium High Den-
sity (HD) Human610-Quad DNA Bead Chips version 1
as described previously (Cox et al. 2012). A total of
620,901 genome-wide markers were genotyped and mark-
ers had a median spacing of 2.7 kb (mean = 4.7 kb)
throughout the genome. In this study all genotyped SNPs
were directly observed via lab-based assays, that is, not
imputed. Individuals with a call rate below 95% and
SNPs with a call rate below 99%, deviating from Hardy–
Weinberg equilibrium (pHWE<1 9 10
7) or with a minor
allele frequency of <1% were excluded.
Statistical modeling
SNPs located within 10 kb of all known NEMP genes were
selected using a custom script developed in R. Gene
boundaries were obtained for /Homo sapiens/ (build hg19)
as a gff3 file, then filtered using a list of mitochondrial pro-
tein names obtained from MitoProteome (Cotter et al.
2004), extending 10 kb in each direction from each gene
using a custom perl script. The region of selection was
extended by 10 kb to ensure that regulatory regions were
included in the selection. The gff3 location file was then
intersected with the locations for SNPs genotyped in the NI
population using a custom python script that interfaced
with HTSeq (Hu et al. 2013; Anders et al. 2015).
In total genotype data for 15351 SNPs representing 956
NEMP genes were selected for 315 key Norfolk Island
individuals – 80 migraine sufferers compared to 235 con-
trols (see Table S1 for NEMP gene annotation). A logistic
regression model was used to statistically model the vari-
ant association with migraine. The model included
covariates which were used to adjust for age, sex, and
relatedness within the pedigree. Plink v1.07 (Purcell et al.
2007) was used for the logistic regression model. Since
this study utilizes a gene-centric approach and given the
relatively small sample size of the discovery cohort we set
a relaxed significance threshold of 0.005 for the discovery
phase. SNPs which exceeded this suggestive significance
threshold were moved forward into the replication phase
to assess the validity of findings in an independent, and
general population, migraine cohort.
Replication phase – validation through an
independent migraine cohort
Sample selection
Migraine patients and controls were recruited from the
local South East Queensland region as previously described
(Colson et al. 2004). They were all of Caucasian origin, and
diagnosed as having MA or MO based on criteria specified
by the International Headache Society. An unaffected con-
trol group with no family history of migraine was matched
for age ( 5 years), sex, and ethnicity. Blood samples
obtained from patients were collected through the Geno-
mics Research Centre clinic and DNA was extracted using
a salting out method. Approval for the study protocol was
acquired from QUT’s Ethics Committee (Approval Num-
ber 1300000484). In total 1128 individuals comprising 544
patients and 584 controls were genotyped. Migraine suffer-
ers included both MA and MO subtypes, with 381 MA
patients and 163 MO patients. As is typical of migraine,
samples were skewed in a 3:1 gender ratio with 294 males
and 834 females included.
Molecular methods
Matrix-assisted desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry was used to genotype
each sample in a multiplexed reaction using the Sequenom
(Agena Biosciences) MassARRAY system (Shchepinov
et al. 2001). The time of flight was recorded for each frag-
ment which has a slightly different density according to
genotypes, which were visually checked by the cluster plots
and called according to strict parameters. Dilution and
pooling of annealing and extension primers, amplification
and purification steps, desalting of samples, dispensing to
chip, and acquiring data through MALDI-TOF were all
carried out according to the manufacturer’s instructions.
Statistical modeling
Logistic regression modeling was performed in Plink
v1.07 (Purcell et al. 2007) to test for association between
the 21 SNPs genotyped and migraine susceptibility in a
large Australian Caucasian population. The model was
adjusted for sex to avoid skewing of results. A regression
model was utilized for overall migraine patients as well as
the migraine subtypes MA and MO. In total 1128 indi-
viduals comprising 544 patients and 584 controls were
included in the analysis. Subtype analysis comprised 381
MA patients and 163 MO patients. When correcting for
multiple testing, only a single SNP deviated from HWE
(rs13361997, P = 4.78E-05). This SNP was disregarded
from further analysis. A significance threshold of
P < 0.005 was also set for the replication cohort.
Results
Discovery phase
This study aimed to undertake a gene centric targeted
approach in order to specifically identify the role of
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NEMP genes in relation to migraine susceptibility. In
total 15351 SNPs across 956 NEMP genes were selected
for testing in 315 Norfolk Island individuals and of these,
67 were found to be suggestively associated with migraine
susceptibility (P < 0.005). Key genes were identified
which contain multiple variants exhibiting association
with migraine. These include Sarcosine dehydrogenase
(SARDH), CUB and Sushi multiple domains 1 (CSMD1),
Phosphatidylserine decarboxylase (PISD), fatty acid elon-
gase 6 (ELOVL6), CUB and Sushi multiple domains 3
(CSMD3) and casein kinase 1 gamma 3 (CSNKIG3).
Genes with three or more nominally associated variants
were prioritized for replication as shown in Table 1.
Replication phase
Leading on from the discovery phase where 67 NEMP
SNPs were shown to be suggestively associated with
migraine in the Norfolk Island population (P < 0.005),
variants were chosen for replication to assess the validity
of findings in an Australian Caucasian population. In
total 1128 individuals comprising 544 patients and 584
controls were genotyped. After analyzing all genotyping
results the logistic regression model showed a significant
association between several SNPs and migraine suscepti-
bility (P < 0.005), replicating the findings in the Norfolk
Island population (Table 2). The most significantly asso-
ciated SNPs were located in the genes ELOVL6
(P = 0.00035), SARDH (P = 0.00081), and CSNK1G3
(P = 0.00037). After applying a Bonferroni correction,
three SNPs located in ELOVL6, SARDH and CSNK1G3
pass the significance threshold suggesting a particularly
important role for these genes in migraine susceptibility.
The three SNPs which showed significant association
were implicated in migraine susceptibility in both the
Norfolk Island population and an unrelated migraine
patient-control population, providing clear evidence for
a role between the identified variants and migraine
susceptibility.
Discussion
Mitochondria function primarily to produce a constant
supply of energy to the cells of the body in the form of
ATP. The most efficient conversion of calories from our
fuel intake (food) into useable energy is through the
oxidative phosphorlyative chain under oxidative condi-
tions where glucose is converted to ATP. The main meta-
bolic pathways include glycolysis, the conversion of
acetyl-CoA to GTP and other intermediates through the
citric acid cycle, the pentose phosphate pathway, the urea
cycle, fatty acid oxidation and gluconeogenesis. Molecules
Table 1. Discovery of NEMP genetic variants associated with migraine susceptibility in the Norfolk Island population.
Chr Gene rs ID Position1 Allele Odds ratio MAF cases MAF controls 95% CI lower 95% CI upper P value
8 CSMD1 rs6993396 2924014 T 0.5707 0.2687 0.396 0.3856 0.8152 0.003096
8 CSMD1 rs7828513 3432054 T 0.5825 0.325 0.4414 0.4266 0.87 0.004645
8 CSMD1 rs17066503 3452058 C 3.349 0.06875 0.02087 1.646 7.287 0.001503
8 CSMD1 rs7815959 3460063 C 1.73 0.3438 0.2388 1.164 2.395 0.004444
22 PISD rs5994415 32004588 A 1.726 0.3812 0.2623 1.218 2.464 0.002542
22 PISD rs12171042 32011225 C 1.83 0.4375 0.2982 1.298 2.581 0.0006661
22 PISD rs9956 32015450 C 1.817 0.4375 0.3004 0.6214 1.325 0.0007959
4 ELOVL6 rs11733718 111073867 G 0.5673 0.375 0.5089 0.4098 0.8182 0.001769
4 ELOVL6 rs900328 111074900 C 0.5687 0.375 0.5105 0.4066 0.8139 0.001778
4 ELOVL6 rs7681294 111082310 T 0.5882 0.375 0.5022 0.4209 0.8403 0.003141
8 CSMD3 rs16883344 113282795 A 3.833 0.05 0.01408 1.481 9.163 0.004581
8 CSMD3 rs16883388 113316520 C 6.973 0.03125 0.004735 1.941 23.69 0.00258
8 CSMD3 rs16883751 113500330 A 2.794 0.06875 0.02186 1.578 6.914 0.003875
5 CSNK1G3 rs9327298 122850321 A 1.697 0.35 0.2377 1.205 2.475 0.003648
5 CSNK1G3 rs4530754 122855416 G 0.5767 0.3438 0.473 0.4101 0.8305 0.002708
5 CSNK1G3 rs7705070 122862876 T 1.696 0.35 0.2377 1.203 2.478 0.003838
5 CSNK1G3 rs7737667 122875622 G 1.697 0.35 0.2377 1.205 2.475 0.003648
5 CSNK1G3 rs2052485 122882219 A 0.5863 0.3438 0.4664 0.4216 0.852 0.003828
5 CSNK1G3 rs6595459 122908361 A 0.5863 0.3438 0.4664 0.4216 0.852 0.003828
5 CSNK1G3 rs10037048 122961813 C 0.5848 0.3187 0.4426 0.4115 0.8436 0.003881
9 SARDH rs2073815 136573412 C 1.683 0.5813 0.4557 1.18 2.33 0.003393
9 SARDH rs522676 136579589 C 0.485 0.2062 0.3385 0.338 0.7629 0.0007839
9 SARDH rs916620 136596750 A 0.5372 0.2125 0.3311 0.3642 0.816 0.003012
9 SARDH rs493901 136600201 C 0.5578 0.35 0.4856 0.4019 0.8096 0.001491
1Genomic position according to build Hg19 of the human genome.
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from our dietary intake are metabolized according to
their properties and the end products are passed along
the OXPHOS units in the mitochondria to produce
energy (Wallace 2005).
Reactive Oxygen Species (ROS) are produced as
biproducts of the energy conversion process and can have
damaging effects on cells if they are allowed to accumu-
late (McCord 2000). Additional functions of the mito-
chondria include calcium homeostasis which is critical for
neuronal function and initiation of apoptosis. Mitochon-
dria occur in proportion to each tissue’s energy require-
ments with muscle and nervous tissues containing several
thousand mitochondria per cell. It has been well estab-
lished that mitochondrial dysfunction affects the tissues
with the highest energy requirements and that the most
severe mitochondrial disorders are neuromuscular diseases
(Cordeiro et al. 2009). It has been hypothesized that the
role of mitochondrial dysfunction in neurological condi-
tions has been overlooked by the medical community and
that further scientific investigations in this arena are war-
ranted. This is the first study to comprehensively investi-
gate the role of NEMPs which are critically involved in
mitochondrial function in relation to migraine suscepti-
bility (Wallace 2005).
This study identified, for the first time, a link between
genetic variants influencing mitochondrial function and
migraine susceptibility providing molecular genetic evi-
dence that mitochondrial dysfunction plays an important
role in migraine susceptibility. The three key genes identi-
fied are important for metabolic pathways and could rep-
resent novel therapeutic targets. The discovery phase of
this study identified 67 (P < 0.005) NEMP variants sug-
gestively associated with migraine susceptibility. Several
SNPs were prioritized for replication in an outbred Aus-
tralian Caucasian migraine population to assess the valid-
ity of these findings in a more general context, including
multiple variants in the top candidate genes. Genes with
three or more nominal associations were included in
order to examine the gene as a whole in the migraine dis-
ease pathway. The replication study supported significant
association with the genes ELOVL6 (P = 0.00035),
SARDH (P = 0.00081), and CSNK1G3 (P = 0.00037) and
migraine. In total three SNPs were found to be significant
in both the genetically isolated Norfolk Island population
and an independent migraine patient-control cohort.
Given the biological plausibility and clear replication in a
second population the results support a relationship
between NEMP genes and migraine susceptibility.
The most significant finding from the replication study
was the association between ELOVL6 and migraine, a
nuclear encoded gene which is transported into the mito-
chondrial matrix and plays a key role in energy metabo-
lism. Within this key gene, we found rs7681294 to be
associated with migraine susceptibility (P = 0.000349).
The odds ratio of 0.6715 suggests that individuals who
carry the C>T change are protected by the T allele. This
gene encodes for an enzyme in humans which catalyzes
the elongation of saturated and monounsaturated fatty
acids with 12, 14 and 16 carbons. It has been found to be
expressed in fatty tissues of the body and a recent study
has provided evidence for this to be a new candidate gene
involved in energy deficiencies with variants in this gene
associated with insulin sensitivity, suggesting an impor-
tant role in metabolic processes (Morcillo et al. 2011).
Significant associations were also found between the
NEMP gene SARDH (P = 0.000808) and migraine suscep-
tibility providing evidence that genetic variation in
nuclear encoded genes which are mitochondrially
expressed may play an important role in migraine. Sar-
cosine dehydrogenase situated on chromosome 9 encodes
for an enzyme which is localized to the mitochondrial
matrix and catalyzes the oxidative demethylation of sarco-
sine. Mutations in this gene have been associated with
sarcosinemia, a mild inborn error of metabolism (Scott
et al. 1970). Some reports have suggested severe problems
associated with this disease including developmental delay
and neurological problems (Meissner and Mayatepek
1997). Casein kinase 1 gamma 3 (CSNKIG3) encodes a
member of a family of serine/threonine protein kinases
that phosphorylate caseins and other acidic proteins. This
gene plays an important role in basic human metabolic
processes (Davidson et al. 2005).
This is the first molecular genetic study to comprehen-
sively investigate the role of NEMPs in migraine suscepti-
bility and we present empirical evidence for the first time
to establish a link between mitochondrial dysfunction and
migraine. This study shows a significant link between
genes involved in mitochondrial function and migraine in
both a genetically isolated population, as well as an out-
bred Australian Caucasian population. Three new key
Table 2. NEMP genetic variants which show association with migraine in an independent patient-control population.
Chr SNP Allele Odds ratio MAF cases MAF controls P value Gene Function
4 rs7681294 T 0.6715 0.409 0.4801 0.000349 ELOVL6 Intronic variant
9 rs2073815 C 1.434 0.4598 0.3764 0.000808 SARDH Synonymous codon
5 rs9327298 A 0.146 0.005076 0.08613 0.000373 CSNK1G3 Intronic variant
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candidate genes were identified in this study, showing a
novel relationship between metabolic pathways and
migraine susceptibility.
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